Skip to main content
Clinical Trials/CTRI/2026/03/106326
CTRI/2026/03/106326Not yet recruitingNot Applicable

COMPARATIVE STUDY OF Q SWITCHED ND YAG LASER VS PICOSECOND LASER FOR TREATMENT OF VARIOUS PIGMENTARY DISORDERS USING A SPLIT LESION DESIGN

Department of Dermatology and Venereology and Leprosy1 site in 1 country36 target enrollmentStarted: March 25, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
36
Locations
1
Primary Endpoint
Picosecond Nd:YAG laser may perform better than Q Switched Nd:YAG in terms of safety and efficacy

Study Overview

Brief Summary

Pigmentary disorders are common dermatological conditions that frequently affect individuals with skin of color, including Asian and Indian populations, often causing significant psychosocial distress

The visible nature of these lesions commonly impacts an individuals quality of life

The following study will compare the efficacy and safety profiles of both picosecond Nd:YAG and Q Switched Nd:YAG lasers for hyperpigmentary diorders in Indian skin type

This study would first of its kind especially in Indian population

Study Design

Study Type
Interventional
Allocation
Other
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients above 18 years.
  • Presence of one or more hyperpigmentary disorders amenable to Nd:YAG laser therapy as per the literature.
  • No treatment taken for the condition (topical/ oral/ procedural) in the last 6 months.
  • Written informed consent to participate in the study and comply with the treatment schedule, follow-up appointments, and post-treatment care instructions.

Exclusion Criteria

  • Unwillingness to consent to participate in the study.
  • Pregnancy and Lactation.
  • Increased Sensitivity to Light.
  • Scars or Florid inflammation of the tattooed skin or area immediately surrounding it.
  • Treatment taken for the pigmentary condition in the last 6 months.
  • Active Skin Conditions: No Active cutaneous infections (bacterial, viral, or fungal) in or near the treatment area.
  • No History of recurrent herpes simplex virus infection in the treatment area, unless prophylactic antiviral therapy is administered.
  • No Active disease with Koebnerization such as lichen planus pigmentosus, Riehl’s melanosis, etc.
  • Concomitant treatment for the pigmentary condition except sunscreen.

Outcomes

Primary Outcomes

Picosecond Nd:YAG laser may perform better than Q Switched Nd:YAG in terms of safety and efficacy

Time Frame: 4 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Department of Dermatology and Venereology and Leprosy
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr. Amogh Kirtane

Rajiv Gandhi Medical College and Chhatrapati Shivaji Maharaj Hospital

Study Sites (1)

Loading locations...

Similar Trials